Skip to content
Oteseconazole
Vivjoa (oteseconazole) is a small molecule pharmaceutical. Oteseconazole was first approved as Vivjoa on 2022-04-26. It is used to treat vulvovaginal candidiasis in the USA.
Download report
Favorite
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
infectionsD007239
urogenital diseasesD000091642
Trade Name
FDA
EMA
Vivjoa
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Oteseconazole
Tradename
Company
Number
Date
Products
VIVJOAMycovia PharmaceuticalsN-215888 RX2022-04-26
1 products, RLD, RS
Labels
FDA
EMA
Brand Name
Status
Last Update
vivjoaNew Drug Application2022-07-12
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
vulvovaginal candidiasisEFO_0007543D002181B37.3
Agency Specific
FDA
EMA
Expiration
Code
OTESECONAZOLE, VIVJOA, MYCOVIA PHARMS
2032-04-26GAIN
2027-04-26NCE
Patent Expiration
Patent
Expires
Flag
FDA Information
Oteseconazole, Vivjoa, Mycovia Pharms
98404922036-03-17DS, DP
104147512036-03-17DS, DP
112479812033-05-09U-3366
82369622031-04-22DS, DP
87542272031-04-22U-3366
ATC Codes
J: Antiinfectives for systemic use
J02: Antimycotics for systemic use
J02A: Antimycotics for systemic use
J02AC: Triazole and tetrazole derivatives
J02AC06: Oteseconazole
HCPCS
No data
Clinical
Clinical Trials
7 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
No data
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Vulvovaginal candidiasisD002181EFO_0007543B37.3235
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
OnychomycosisD014009B35.111
Tinea pedisD014008EFO_0007512B35.311
Indications Phases 1
No data
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameOTESECONAZOLE
INNoteseconazole
Description
Oteseconazole is an organic molecular entity.
Classification
Small molecule
Drug classsystemic antifungals (miconazole type)
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
O[C@@](Cn1cnnn1)(c1ccc(F)cc1F)C(F)(F)c1ccc(-c2ccc(OCC(F)(F)F)cc2)cn1
Identifiers
PDB
CAS-ID1340593-59-0
RxCUI
ChEMBL IDCHEMBL3311228
ChEBI ID
PubChem CID77050711
DrugBankDB13055
UNII IDVHH774W97N (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 76 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
0 adverse events reported
View more details